• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎(COVID-19)感染继发暴发性心肌炎的非典型表现

An Atypical Presentation of Fulminant Myocarditis Secondary to COVID-19 Infection.

作者信息

Richard Ivan, Robinson Bracha, Dawson Amanda, Aya Ashley, Ali Rana

机构信息

Internal Medicine, Hackensack Meridian Ocean Medical Center, Brick, USA.

出版信息

Cureus. 2020 Jul 14;12(7):e9179. doi: 10.7759/cureus.9179.

DOI:10.7759/cureus.9179
PMID:32802614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7425826/
Abstract

The potential etiologies of fulminant myocarditis include autoimmune diseases, infections, drug hypersensitivity, and drug/toxin reactions. We present an atypical case of fulminant myocarditis in a patient with a history of diabetic ketoacidosis with recent novel coronavirus (COVID-19) infection, who presented with acute upper gastrointestinal bleeding. The patient improved with a three-day course of methylprednisolone 1 gram daily.

摘要

暴发性心肌炎的潜在病因包括自身免疫性疾病、感染、药物过敏以及药物/毒素反应。我们报告了一例非典型暴发性心肌炎病例,患者有糖尿病酮症酸中毒病史,近期感染新型冠状病毒(COVID-19),并出现急性上消化道出血。患者接受了为期三天、每日1克甲泼尼龙的治疗后病情好转。

相似文献

1
An Atypical Presentation of Fulminant Myocarditis Secondary to COVID-19 Infection.新型冠状病毒肺炎(COVID-19)感染继发暴发性心肌炎的非典型表现
Cureus. 2020 Jul 14;12(7):e9179. doi: 10.7759/cureus.9179.
2
Fulminant type 1 diabetes mellitus and fulminant viral myocarditis. A case report and literature review.暴发性1型糖尿病与暴发性病毒性心肌炎。一例病例报告及文献综述。
Int Heart J. 2015;56(2):239-44. doi: 10.1536/ihj.14-250. Epub 2015 Feb 27.
3
Parvovirus B19 Myocarditis of Fulminant Evolution.暴发性进展型细小病毒B19心肌炎
Cardiol Res. 2017 Aug;8(4):172-175. doi: 10.14740/cr580w. Epub 2017 Aug 23.
4
Echocardiographic findings in fulminant and acute myocarditis.暴发性和急性心肌炎的超声心动图表现
J Am Coll Cardiol. 2000 Jul;36(1):227-32. doi: 10.1016/s0735-1097(00)00690-2.
5
The Prognostic Role of QTc Interval in Acute Myocarditis.QTc间期在急性心肌炎中的预后作用
Acta Cardiol Sin. 2016 Mar;32(2):223-30. doi: 10.6515/acs20150226a.
6
A case of fulminant type 1 diabetes mellitus accompanied by myocarditis.暴发型 1 型糖尿病伴心肌炎 1 例
Endocr J. 2011;58(7):553-7. doi: 10.1507/endocrj.k11e-007. Epub 2011 May 7.
7
Successful use of plasma exchange in fulminant lupus myocarditis coexisting with pneumonia: A case report.血浆置换成功用于暴发性狼疮性心肌炎合并肺炎:一例报告
World J Clin Cases. 2020 May 26;8(10):2056-2065. doi: 10.12998/wjcc.v8.i10.2056.
8
Fulminant myocarditis treated with percutaneous cardiopulmonary support system (PCPS).采用经皮心肺支持系统(PCPS)治疗暴发性心肌炎。
Ann Thorac Cardiovasc Surg. 2008 Apr;14(2):75-80.
9
Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis.循环心肌肌钙蛋白水平与急性暴发性病毒性心肌炎患儿的心功能障碍。
Acta Paediatr. 2010 Oct;99(10):1510-6. doi: 10.1111/j.1651-2227.2010.01882.x. Epub 2010 Jun 8.
10
Factors and values at admission that predict a fulminant course of acute myocarditis: data from Tokyo CCU network database.预测急性心肌炎暴发性病程的入院因素及数值:来自东京重症监护病房网络数据库的数据
Heart Vessels. 2017 Aug;32(8):952-959. doi: 10.1007/s00380-017-0960-0. Epub 2017 Mar 3.

引用本文的文献

1
Evaluation of cardiac biomarkers among dead and alive COVID-19 patients in Southwest Iran.伊朗西南部新冠病毒病死亡和存活患者心脏生物标志物的评估
J Family Med Prim Care. 2024 Sep;13(9):3931-3937. doi: 10.4103/jfmpc.jfmpc_1964_23. Epub 2024 Sep 11.
2
Fulminant Myocarditis with SARS-CoV-2 Infection: A Narrative Review from the Case Studies.新型冠状病毒2型感染所致暴发性心肌炎:病例研究的叙述性综述
Can J Infect Dis Med Microbiol. 2024 Mar 4;2024:9000598. doi: 10.1155/2024/9000598. eCollection 2024.
3
Atypical Complications during the Course of COVID-19: A Comprehensive Review.

本文引用的文献

1
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.首例 COVID-19 合并暴发性心肌炎:病例报告及启示
Infection. 2020 Oct;48(5):773-777. doi: 10.1007/s15010-020-01424-5. Epub 2020 Apr 10.
2
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.COVID-19 心原性休克中冠状病毒的心肌定位。
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
3
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎(COVID-19)患者的心脏受累。
COVID-19 病程中的非典型并发症:全面综述。
Medicina (Kaunas). 2024 Jan 15;60(1):164. doi: 10.3390/medicina60010164.
4
Clinical outcome of established diagnostic and treatment modalities of COVID-19-associated myocarditis: a systematic review.新型冠状病毒肺炎相关心肌炎既定诊断和治疗方式的临床结局:一项系统评价
Ann Med Surg (Lond). 2023 Jun 16;85(7):3583-3594. doi: 10.1097/MS9.0000000000000964. eCollection 2023 Jul.
5
Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review.新型冠状病毒感染与新冠疫苗接种后暴发性心肌炎和心源性休克:一项系统文献综述
J Clin Med. 2023 Feb 25;12(5):1849. doi: 10.3390/jcm12051849.
6
Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review.严重 COVID-19 相关心肌炎合并心源性休克 - 辅助设备治疗 - 一例报告并复习。
BMC Anesthesiol. 2022 Dec 12;22(1):385. doi: 10.1186/s12871-022-01890-4.
7
COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports.成人 COVID-19 相关心肌炎:病例报告的系统评价
J Clin Med. 2022 Sep 21;11(19):5519. doi: 10.3390/jcm11195519.
8
Comorbidities and Symptomatology of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-Related Myocarditis and SARS-CoV-2 Vaccine-Related Myocarditis: A Review.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关心肌炎和SARS-CoV-2疫苗相关心肌炎的合并症与症状学:综述
Cureus. 2022 Apr 12;14(4):e24084. doi: 10.7759/cureus.24084. eCollection 2022 Apr.
9
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.COVID-19 阳性患者心肌受累的临床变异型:2020 年的累积经验。
Heart Fail Rev. 2022 Jul;27(4):1341-1353. doi: 10.1007/s10741-021-10129-2. Epub 2021 Jul 2.
10
Corticosteroid Therapy in Management of Myocarditis Associated with COVID-19; a Systematic Review of Current Evidence.皮质类固醇疗法在新型冠状病毒肺炎相关心肌炎管理中的应用;当前证据的系统评价
Arch Acad Emerg Med. 2021 Apr 16;9(1):e32. doi: 10.22037/aaem.v9i1.1153. eCollection 2021.
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
4
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
7
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
8
Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis.中华医学会心血管病学分会成人暴发性心肌炎诊断和治疗专家共识。
Sci China Life Sci. 2019 Feb;62(2):187-202. doi: 10.1007/s11427-018-9385-3. Epub 2018 Dec 3.
9
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.致病性人类冠状病毒感染:细胞因子风暴和免疫病理学的成因及后果
Semin Immunopathol. 2017 Jul;39(5):529-539. doi: 10.1007/s00281-017-0629-x. Epub 2017 May 2.
10
Myocarditis.心肌炎。
Circ Res. 2016 Feb 5;118(3):496-514. doi: 10.1161/CIRCRESAHA.115.306573.